Botulinum Toxin A Injection into the Subscapularis Muscle to Treat Intractable Hemiplegic Shoulder Pain
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective To evaluate the beneficial effect of botulinum toxin A (Botox) injection into the subscapularis muscle on intractable hemiplegic shoulder pain.Methods Six stroke patients with intractable hemiplegic shoulder pain were included. Botulinum toxin A was injected into the subscapularis muscle. Intractable hemiplegic shoulder pain was evaluated using an 11-point numerical rating scale. Pain-free range of motion was assessed for shoulder abduction and external rotation. The spasticity of the shoulder internal rotator was measured using the modified Ashworth scale. Assessments were carried out at baseline and at 1, 2, 4, and, if possible, 8 weeks.Results Intractable hemiplegic shoulder pain was improved (p=0.004) after botulinum toxin injection into the subscapularis muscle. Restricted shoulder abduction (p=0.003), external rotation (p=0.005), and spasticity of the shoulder internal rotator (p=0.005) were also improved. Improved hemiplegic shoulder pain was correlated with improved shoulder abduction (r=–1.0, p<0.001), external rotation (r=–1.0, p<0.001), and spasticity of the internal rotator (r=1.0, p<0.001).Conclusion Botulinum toxin A injection into the subscapularis muscle appears to be valuable in the management of intractable hemiplegic shoulder pain.
Abstract
Objective To evaluate the beneficial effect of botulinum toxin A (Botox) injection into the subscapularis muscle on intractable hemiplegic shoulder pain.Methods Six stroke patients with intractable hemiplegic shoulder pain were included. Botulinum toxin A was injected into the subscapularis muscle. Intractable hemiplegic shoulder pain was evaluated using an 11-point numerical rating scale. Pain-free range of motion was assessed for shoulder abduction and external rotation. The spasticity of the shoulder internal rotator was measured using the modified Ashworth scale. Assessments were carried out at baseline and at 1, 2, 4, and, if possible, 8 weeks.Results Intractable hemiplegic shoulder pain was improved (p=0.004) after botulinum toxin injection into the subscapularis muscle. Restricted shoulder abduction (p=0.003), external rotation (p=0.005), and spasticity of the shoulder internal rotator (p=0.005) were also improved. Improved hemiplegic shoulder pain was correlated with improved shoulder abduction (r=–1.0, p<0.001), external rotation (r=–1.0, p<0.001), and spasticity of the internal rotator (r=1.0, p<0.001).Conclusion Botulinum toxin A injection into the subscapularis muscle appears to be valuable in the management of intractable hemiplegic shoulder pain.
참고문헌 (30)
- Adey-Wakeling Z, "Incidence and associations of hemiplegic shoulder pain poststroke: prospective population-based study", Arch Phys Med Rehabil, 96, pp.241-7.e1~ (2015)
- Aras MD, "Shoulder pain in hemiplegia: results from a national rehabilitation hospital in Turkey", Am J Phys Med Rehabil, 83, pp.713~719 (2004)
- Lo SF, "Arthrographic and clinical findings in patients with hemiplegic shoulder pain", Arch Phys Med Rehabil, 84, pp.1786~1791 (2003)
- Tavora DG, "MRI findings in the painful hemiplegic shoulder", Clin Radiol, 65, pp.789~794 (2010)
- Murie-Fernandez M, "Painful hemiplegic shoulder in stroke patients: causes and management", Neurologia, 27, pp.234~244 (2012)
- Snels IA, "Treatment of hemiplegic shoulder pain in the Netherlands:results of a national survey", Clin Rehabil, 14, pp.20~27 (2000)
- Gamble GE, "Poststroke shoulder pain: a prospective study of the association and risk factors in 152patients from a consecutive cohort of 205 patients presenting with stroke", Eur J Pain, 6, pp.467~474 (2002)
- Singh JA, "Intra-articular botulinum toxin A for refractory shoulder pain:a randomized, double-blinded, placebo-controlled trial", Transl Res, 153, pp.205~216 (2009)
- Roosink M, "Persistent shoulder pain in the first 6 months after stroke: results of a prospective cohort study", Arch Phys Med Rehabil, 92, pp.1139~1145 (2011)
- Jankovic J, "Botulinum toxin in clinical practice", J Neurol Neurosurg Psychiatry, 75, pp.951~957 (2004)
- 이혜선, "Paroxysmal Autonomic Instability With Dystonia Managed Using Chemodenervation Including Alcohol Neurolysis and Botulinum Toxin Type A Injection: A Case Report", Annals of Rehabilitation Medicine, 39(2), pp.308~312 (2015), 대한재활의학회
- Yelnik AP, "Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A", J Neurol Neurosurg Psychiatry, 78, pp.845~848 (2007)
- Jabbari B, "Botulinum neurotoxins in the treatment of refractory pain", Nat Clin Pract Neurol, 4, pp.676~685 (2008)
- Wissel J, "Management of spasticity associated pain with botulinum toxin A", J Pain Symptom Manag, 20, pp.44~49 (2000)
- Wu T, "Effectiveness of botulinum toxin for shoulder pain treatment : a systematic review and meta-analysis", Arch Phys Med Rehabil, 96, pp.2214~2220 (2015)
- de Boer KS, "Shoulder pain and external rotation in spastic hemiplegia do not improve by injection of botulinum toxin A into the subscapular muscle", J Neurol Neurosurg Psychiatry, 79, pp.581~583 (2008)
- Lim JY, "Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: a randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide", Stroke, 39, pp.126~131 (2008)
- Harden RN, "Proposed new diagnostic criteria for complex regional pain syndrome", Pain Med, 8, pp.326~331 (2007)
- Klit H, "Central post-stroke pain: clinical characteristics, pathophysiology, and management", Lancet Neurol, 8, pp.857~868 (2009)
- Yelnik AP, "Treatment of pain and limited movement of the shoulder in hemiplegic patients with botulinum toxin A in the subscapular muscle", Eur Neurol, 50, pp.91~93 (2003)
- Rha DW, "Ultrasound-guided lateral approach for needle insertion into the subscapularis for treatment of spasticity", Arch Phys Med Rehabil, 93, pp.1147~1152 (2012)
- Chang YW, "Prediction of muscle force involved in shoulder internal rotation", J Shoulder Elbow Surg, 9, pp.188~195 (2000)
- Hecht JS, "Subscapular nerve block in the painful hemiplegic shoulder", Arch Phys Med Rehabil, 73, pp.1036~1039 (1992)
- Braun RM, "Surgical treatment of the painful shoulder contracture in the stroke patient", J Bone Joint Surg Am, 53, pp.1307~1312 (1971)
- Mense S, "Neurobiological basis for the use of botulinum toxin in pain therapy", J Neurol, 251(1), pp.I1~I7 (2004)
- Jabbari B, "Treatment of refractory pain with botulinum toxins: an evidence-based review", Pain Med, 12, pp.1594~1606 (2011)
- Cosgrove AP, "Botulinum toxin in the management of the lower limb in cerebral palsy", Dev Med Child Neurol, 36, pp.386~396 (1994)
- Childers MK, "Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke", Arch Phys Med Rehabil, 85, pp.1063~1069 (2004)
- Angaut-Petit D, "Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features", Neuroscience, 37, pp.799~808 (1990)
- Marco E, "Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial", J Rehabil Med, 39, pp.440~447 (2007)